Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Genomic medicines: the coming waves?

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Nature Reviews Drug Discovery 22, 691-692 (2023)


Supplementary Information

  1. Supplementary information

Competing Interests

J.W. and B.C. are employees of The Boston Consulting Group (BCG), a management consultancy that works with the world's leading biopharmaceutical companies. W.X. was an employee of BCG at the time the article was written. The research for this specific article was funded by BCG's healthcare practice and represents the views of BCG and does not represent the views of Millennium.

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links